Price $8.19 |
Market Cap
555.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
2.73
|
P/S
18.14
|
Dividend %
-
|
|
P/CF
28.3
|
P/FCF
-
|
Op. Cash Flow
-67.6K
|
FCF
-1.0
|
|
Op. Margin
-301.80%
|
Net Margin
-292.10%
|
ROE
-41.70%
|
ROI
-45.50%
|
|
ROA
-33.90%
|
EPS Growth
18.10%
|
Current Ratio
10.6
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Societal CDMO Inc (SCTL) | $0.76 | - | - | 99.3M | Strong Buy |
| Taysha Gene Therapies Inc (TSHA) | $0.68 | - | - | 46M | Strong Buy |
| Medicine Man Technologies Inc (SHWZ) | $1.01 | - | - | 59.4M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $7.21 | - | - | 9.93B | Strong Buy |
| Applied DNA Sciences Inc (APDN) | $1.10 | - | - | 14.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
